SHAREHOLDER ALERT: Morris Kandinov Investigating MASI, EXTR, POWW, and EP; Shareholders are Encouraged to Contact the Firm
08. Januar 2025 06:00 ET
|
Morris Kandinov, LLP
National law firm Morris Kandinov is investigating Masimo Corporation, Extreme Networks, Inc., AMMO Incorporated, and Empire Petroleum Corporation.
Kuehn Law Encourages Investors of Empire Petroleum Corp to Contact Law Firm
06. Januar 2025 22:11 ET
|
KUEHN LAW, PLLC
Kuehn Law is investigating Empire Petroleum Corp for potential fiduciary breaches. Shareholders should contact Justin Kuehn, Esq.
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
17. August 2024 11:27 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
16. August 2024 07:00 ET
|
Sol-Gel Technologies Ltd.
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
Empire Petroleum Announces Commencement of Previously Announced Rights Offering
07. März 2024 20:51 ET
|
Empire Petroleum Corporation
EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING
BioSig Announces Reduction of its Workforce
20. Februar 2024 10:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a...
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
06. Februar 2024 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces Reverse Stock Split
31. Januar 2024 11:15 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and...
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
30. Januar 2024 08:30 ET
|
BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
06. Dezember 2023 14:20 ET
|
BioSig Technologies, Inc.
Westport, CT, Dec. 06, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...